<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01269450</url>
  </required_header>
  <id_info>
    <org_study_id>0023-08-EMC</org_study_id>
    <nct_id>NCT01269450</nct_id>
  </id_info>
  <brief_title>Progesterone and Second Trimester Bleeding</brief_title>
  <official_title>The Impact of Progesterone on the Risk of Preterm Birth Among Women With Second Trimester Bleeding. A Double Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Working hypothesis and aims:

      To investigate whether progesterone treatment affects the incidence of preterm labor compared
      to placebo, among women with 2nd trimester bleeding.

      The participants will be allocated through randomization to a study or control group. Women
      in the study group will receive micronized progesterone 200 mg (Utrogestan, company) with an
      intra-vaginal tablet once daily while the control group will receive placebo. Both women and
      medical staff will be blinded to group allocation. Treatment will commence on the day of
      inclusion to the study, but not before 16 weeks and will continue until 36 weeks gestation.
      Data will be collected after the conclusion of pregnancy regarding the maternal and neonatal
      outcome.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow recruitment
  </why_stopped>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of spontaneous preterm birth - before 37 weeks.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal and fetal outcomes</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Antepartum Bleeding</condition>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Utrogestan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>micronized progesterone 200 mg (Utrogestan)</intervention_name>
    <description>micronized progesterone 200 mg (Utrogestan, company) as an intra-vaginal tablet once daily</description>
    <arm_group_label>Utrogestan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo 200mg vaginal tablets</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Viable pregnancy

          -  Gestational age between 13 to 26 weeks

          -  Vaginal bleeding from uterine origin

          -  Singleton pregnancy

          -  Normal clotting tests

          -  Hemodynamically stable woman

        Exclusion Criteria:

          -  Water leak

          -  Signs of preterm labor

          -  Fetal malformations incompatible with life

          -  Uterine malformations and other maternal conditions, i.e. liver disease, breast
             cancer, active thromboembolic state

          -  Past preterm birth
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RAED SALIM, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek medical center affiliated to the Rappaport faculty of medicine, Technion, Haifa, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emek medical center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>dEP ob/gyn, Hillel Yaffe Medical Center.</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dep. OB/GYN, The Nazareth Hospital, E.M.M.S</name>
      <address>
        <city>Nazareth</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://hospitals.clalit.co.il/hospitals/emek/he-il/Clinics/GynecologyAndDelivery/Pages/WomenAndBirthDepartment.aspx</url>
    <description>Dep OB/GY, Emek Medical Center</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2011</study_first_posted>
  <last_update_submitted>January 20, 2018</last_update_submitted>
  <last_update_submitted_qc>January 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Raed Salim</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>second trimester vaginal bleeding</keyword>
  <keyword>late abortion</keyword>
  <keyword>preterm birth</keyword>
  <keyword>progesterone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

